Pre-conference Session
- Date:
- Time: -
- Track: Education
- CME/CE: 3
- Q & A: None
Additional fee session
Sponsored by the Association of Directors of Geriatric Academic Programs (ADGAP)
Amyloid Antibodies for Alzheimer’s and Your Academic Geriatric Program
This session will summarize the evidence for amyloid antibodies and discuss the role of the academic geriatric program from a clinical, educational, and research perspective. Learning Objectives: (1) describe the current state of the science on Amyloid Antibodies; (2) utilize approaches learned to support your programs; and (3) identify the roles of Geriatricians in the research on Amyloid Antibodies.
| Time | Agenda Item |
|---|---|
| 2:30 PM | Welcome Eric Widera, MD |
| 2:35 PM | A Summary of the Evidence for Amyloid Antibodies Jason Karlawish, MD Eric Widera, MD |
| 2:55 PM | What AGS is Doing: Policy Efforts & Curriculum Michael Harper, MD Mark Supiano, MD |
| 3:10 PM | Development of Geriatrics Teams in Prescribing and Managing MABs Heather Whitson, MD, MHS (moderator) Hamid R. Okhravi, MD Daniel Parker, MD Catherine Sarkisian, MD, MSHS |
| 3:35 PM | Q & A |
| 3:50 PM | Preparing Geriatrics Fellows for a New Era in Diagnosing and Treating Alzheimer’s Disease Esther Oh, MD (moderator) Halima Amjad, MD, PhD, MPH Jo Cleveland, MD Angela Hanson, MD |
| 4:15 PM | Q & A |
| 4:30 PM | Break |
| 4:40 PM | Integrating Alzheimer’s Disease and Related Dementias into your Academic Program's Research Portfolio Sanjay Asthana, MD (moderator) Sharon Brangman, MD Cynthia Carlsson, MD, MS Joshua Chodosh, MD, MSHS |
| 5:05 PM | Q & A |
| 5:20 PM | Closing Remarks Eric Widera, MD |